Nasic-cur

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nasic-cur

Quick Facts

Property Description
Active ingredient Dexpanthenol (D-(+)-Pantothenyl alcohol)
Form Nasal Spray (Aqueous Solution)
Pharmacological class Rhinological Agent / Cicatrizant
Common use Supportive healing of damaged nasal mucosa
Origin Provitamin (Derivative of Vitamin B5)

What is the Medicinal Identity of Nasic-cur?

Nasic-cur is an authorized medicinal product classified as a Rhinological agent, delivered in the specific dosage form of a nasal spray utilizing an aqueous solution vehicle. This preparation is a monopreparation, meaning its therapeutic effect relies solely on one key active compound, Dexpanthenol, distinguishing its function from combination nasal products. Pharmacologically, the medication is broadly categorized as a cicatrizant, or an agent for the treatment of wounds and ulcers (ATC code D03AX03), confirming its defined purpose as a localized supportive agent for tissue repair. This identity makes it a suitable choice when the priority is focused on mucosal recovery.

Dexpanthenol: Composition and Role as a Provitamin

The sole active ingredient is Dexpanthenol (D-(+)-Pantothenyl alcohol, INN). Dexpanthenol is officially categorized as a Provitamin because it is a derivative of Pantothenic acid (Vitamin B5), which is an essential nutrient. Once absorbed by the nasal tissue cells, the body rapidly converts Dexpanthenol into the biologically active Pantothenic acid. Dexpanthenol has the ability to enhance the quality of tissue regeneration in topical applications.

What is the General Purpose of Dexpanthenol Nasal Spray?

The high-level general purpose of this medication is to serve as a wound healing promoter, providing essential supportive treatment for the healing process of the nasal mucous membrane. For example, it is typically used in situations where the nasal lining is dry or irritated following environmental stress or minor localized damage. By supplying this provitamin, the spray fundamentally supports the body’s natural capacity for tissue repair and epithelium protection, encouraging the restoration of the mucosa's integrity. This restorative focus assists the damaged or irritated nasal lining in regaining its crucial protective functions.

What side effects are possible with Nasic-cur?

Possible Side Effects and Safety Information

The safety profile of Nasic-cur (Dexpanthenol) nasal spray is characterized by a low incidence of adverse reactions, with regulatory documents primarily focusing on the potential for immune system response. The medicinal identity as a monotherapy for mucosal support limits the risks commonly associated with other classes of nasal medication.

Documented Adverse Reactions and Frequency

Adverse effects listed in official prescribing information are generally classified as rare.

System-Organ Class Documented Adverse Reactions (Rare)
Immune System Disorders Hypersensitivity reactions
Skin and Subcutaneous Tissue Disorders Manifestations of allergy, such as rash, pruritus (itching), and urticaria (hives)

Serious adverse reactions, though exceedingly rare, include the potential for severe hypersensitivity reactions, such as anaphylaxis or significant angioedema (swelling). These serious outcomes are classified within the immune system domain.

High-Level Safety Constraints

The most important constraint documented in the product labeling is an absolute restriction against use in individuals with a known hypersensitivity to the active substance, Dexpanthenol, or any of the preparation’s inactive components. Regulatory documents state that no drug interactions are currently known for the active ingredient, Dexpanthenol, when used as directed.

Official prescribing information includes cautionary language regarding the use of Dexpanthenol during pregnancy and lactation (Pregnancy Category C), and notes that safety and effectiveness have not been established for all pediatric uses. These statements reflect standard regulatory practice where specific clinical data for these populations may be limited.

Overdose and Emergency Response

Overdose and when to seek help

This information describes the documented profile for overdose of Nasic-cur (Dexpanthenol Nasal Spray), based strictly on authoritative governmental regulatory documents.


Overdose Scope

The active ingredient, Dexpanthenol, is classified in regulatory toxicology data as having a very low acute toxicity profile. Overdose following normal use or minor misuse is not expected to result in severe or life-threatening systemic effects. Documented overdose presentations, primarily associated with the rare event of massive accidental oral ingestion of the solution, are often limited to minimal systemic toxicity and transient, non-specific gastrointestinal symptoms.

Regulatory documentation confirms no specific antidote is known for Dexpanthenol overexposure, and typically no specific measures are required beyond observation.


When to Seek Urgent Help (Regulatory Mandate)

Classification Required Action (Regulatory Phrasing Only)
Suspected or Confirmed Overdose Seek medical advice or contact a poison control center for clinical assessment.
Severe Reaction Contact emergency medical services immediately if any unexpected, severe adverse reaction occurs following misuse.

Management and Monitoring

Treatment for overdose is officially described as symptomatic and supportive treatment. Due to the compound's low risk, extensive hospital monitoring is generally not required unless a massive quantity has been ingested or co-exposure with other substances has occurred. Official labels do not typically specify population-based differences in severity for Dexpanthenol overdose.

Therapeutic Uses of Nasic-cur

What Nasic-cur treats: main uses and benefits

Nasic-cur is a medication indicated for the temporary management of symptoms related to nasal congestion. Its primary therapeutic function is to facilitate relief from discomfort caused by blocked nasal passages and excessive mucus. The medication is commonly used to provide symptomatic support across several clinical scenarios, including the congestion associated with the common cold and seasonal flu. It also helps in the management of nasal symptoms linked to allergic rhinitis (hay fever) and sinusitis.

Providing relief from nasal obstruction supports improved airflow, which may be associated with better comfort during the day and can contribute to a higher quality of rest at night.


Quick Fact: Relief for Nasal Congestion

Nasic-cur is utilized for the short-term relief of symptoms such as a stuffy nose, runny nose, and nasal blockage, helping to ease breathing difficulty.

Eligibility and Restrictions for Use

Official Eligibility Profile for Nasic-cur

This section outlines the population eligibility and restrictions for Nasic-cur, based strictly on official regulatory prescribing information. The active ingredient is Dexpanthenol, and the rules pertain to its use as a nasal monopreparation.


Who Must Not Use This Medicine (Contraindications)

The medicine is absolutely contraindicated for use in any individual with a documented hypersensitivity or allergic reaction to the active substance, Dexpanthenol, or to any of the product’s excipients.


Age-Group and General Eligibility

The product is generally eligible for use in adults and children. While its local topical use is well-established across these age groups, formal regulatory documents for the active ingredient’s systemic form note that safety and effectiveness in the pediatric population have not been definitively established.


Conditional Use (Pregnancy and Lactation)

Status Regulatory Classification Requirement for Use
Pregnancy Category C Use is conditional; a healthcare professional must determine that the potential benefit justifies the potential risk.
Lactation Caution Use requires caution, as it is not known whether the drug is excreted into human milk.

The eligibility profile is not defined by restrictions related to major organ function or systemic comorbidities like hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Nasic-cur, which contains only the active ingredient Dexpanthenol, confirms that the medicinal product has a low potential for systemic interactions. As a localized supportive agent for nasal mucosa healing, this formulation is not associated with the complex pharmacokinetic or pharmacodynamic interactions documented for many systemically absorbed medications.


Official Regulatory Interaction Status

Interaction Type Officially Documented Status
Drug–Drug Interactions None documented
Metabolic Interactions (e.g., CYP-mediated) None documented
Food, Alcohol, or Herbal Interactions None documented
Administration Timing Requirements None documented

Profile Summary

Regulatory prescribing information for Dexpanthenol, when administered as a nasal spray, does not specify any contraindicated combinations or medicines that are restricted from co-administration. The official regulatory profile does not list any substances that are known to alter the systemic exposure of Dexpanthenol (e.g., increased or reduced plasma concentrations). Consequently, the regulatory label imposes no mandatory requirements for spacing the administration of Nasic-cur away from other medicinal products, food, or alcohol, confirming a straightforward interaction profile.

Mechanism of Action

Mechanism of Action

This product operates via a dual-component process involving vascular smooth muscle contraction and epithelial metabolic support.

The decongestant component acts as a direct-acting alpha-adrenergic agonist on receptors (alpha-adrenoceptors) located on blood vessels within the nasal mucosa. Receptor activation initiates the constriction of vascular smooth muscle, a mechanism that controls blood flow and fluid movement in the nasal tissue, resulting in a decrease in mucosal tissue volume.

Conversely, the second component functions as a metabolic precursor converted into Pantothenic acid (Vitamin B5). This conversion is integral to the synthesis of Coenzyme A (CoA), which is necessary for epithelial cell proliferation and the production of structural lipids. This mechanism influences the molecular dynamics required for epithelial barrier maintenance and repair.

These two actions exhibit synergistic interaction, where the rapid vascular constriction facilitates the localized distribution of the metabolic precursor to the epithelial tissue. Continuous receptor stimulation can lead to downregulation of alpha-adrenoceptors, which constitutes a known time-dependent physiological constraint.

Dosage and Administration Information

Nasic-cur is administered exclusively via the topical intranasal route using the metered-dose nasal spray device. The preparation is typically an aqueous solution containing Dexpanthenol at a standard concentration of 50 mg/mL.

The standard administration schedule defines use as necessary (pro re nata) and is intended for short-term application. For adults, the usual labeled dose consists of one to two sprays into each nostril per application. The total frequency of use is strictly limited, with administration generally not exceeding three to four times per day, regardless of the specific clinical context. This frequency constraint establishes the maximum daily exposure limits.

Proper administration technique is crucial for ensuring the accurate dose reaches the nasal mucosa. Prior to the initial use, or following any extended period of disuse, the spray pump must be primed by actuating it several times until a fine mist is reliably expelled. During application, the process involves gently inhaling while actuating the spray into the nostril. Use is typically continued only until the required mucosal healing is supported. The label also specifies that for hygienic reasons, the dispenser should be restricted to use by a single individual. Dosage adjustments may be stipulated for pediatric populations (e.g., children aged 2 years and older), which generally involve a modified maximum daily frequency compared to the adult regimen.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Monotherapy

Nasic-cur is a nasal spray that contains Dexpanthenol as its sole active ingredient. Clinical evidence has primarily focused on Dexpanthenol’s role in supporting the integrity and healing of the nasal mucosa.

Studies have assessed its use in cases of nasal membrane damage or dryness. The compound is structurally related to pantothenic acid (Vitamin B5), which is recognized for its role in supporting the body's natural processes of wound closure and cell renewal.

Key Findings and Applications

Research indicates that Dexpanthenol may help by promoting epithelial cell proliferation and supporting the maintenance of the epidermal barrier function. This property has led to its clinical application in scenarios where the nasal lining has been compromised, such as due to irritation, dryness, or damage following surgical procedures.

Evidence on Nasic-cur and similar Dexpanthenol monotherapies often emphasizes its local effect on the nasal tissue. The following table summarizes the primary focus areas of the compound's use as studied in regulatory and clinical contexts:

Focus Area Supporting Action Evaluated in Studies
Nasal Dryness Assessed for its effect on moisturizing the nasal mucosa
Mucosal Lesions Examined for its role in supporting the natural healing process of damaged tissue
Post-Irritation Support Evaluated for its impact on epithelial recovery after chemical or mechanical stress

Frequently Asked Questions (FAQ)

Common questions about Nasic-cur (FAQ)


Q: What is the main difference between Nasic-cur and regular Nasic nasal spray?

A: Nasic-cur is a monotherapy, meaning it contains Dexpanthenol as its sole active ingredient. This ingredient is used to support the healing and recovery of the nasal mucosa.

Regular Nasic nasal spray typically contains Dexpanthenol and a decongestant (such as Xylometazoline). The inclusion of the decongestant gives it a different primary purpose of relieving a stuffy nose.


Q: Is Nasic-cur considered a moisturizing spray or a medicine?

A: Nasic-cur is classified in regulatory documents as an authorized medicinal product (a Rhinological agent).

Its active ingredient, Dexpanthenol, is recognized for its moisturizing and supportive healing properties. Its defined purpose is to support the body’s natural processes of tissue repair and help restore the integrity of the nasal lining.


Q: Can Nasic-cur be used for a stuffy nose if it doesn't have a decongestant?

A: The official regulatory indications for this product do not list the relief of nasal congestion as a primary therapeutic use.

Its sole active ingredient, Dexpanthenol, is not a decongestant. The primary purpose of Nasic-cur is the supportive treatment of damaged or irritated nasal mucosa, such as from dryness.


Q: Are there any known medications that Nasic-cur is known to interact with?

A: Regulatory prescribing information for Dexpanthenol nasal spray states that no interactions are currently known with other medicinal products.

As a localized supportive agent, this formulation has a low potential for complex interactions with medications taken systemically (throughout the body).


Q: What is the recommended period of use for Nasic-cur before seeing a doctor?

A: Official information indicates that Dexpanthenol nasal sprays are generally intended for short-term use until the nasal lining is supported in its healing.

If symptoms do not improve or if they worsen after a specific period (commonly defined as 7 days, based on the information provided on the local product label) of continuous use, regulatory guidance advises re-evaluating the situation by consulting a healthcare professional.


Q: Can Nasic-cur be used by children of all ages?

A: The product is generally eligible for use in both adults and children.

However, the official documents state that safety and effectiveness may not be definitively established for all pediatric ages. It is necessary to refer to the local product label for specific age restrictions or modified dosing requirements for children.


Q: Is it possible to become reliant on Nasic-cur if used regularly?

A: No. The condition of rebound congestion, which causes reliance or physical dependence, is associated with the prolonged use of nasal decongestants (such as Xylometazoline).

Since Nasic-cur contains only Dexpanthenol, which is a supportive healing agent, this risk is not associated with this specific monotherapy product.


Q: What should I do if Nasic-cur makes my nose feel more irritated or dry?

A: If a patient experiences an adverse reaction, such as persistent irritation, increased dryness, or signs of an allergic reaction (e.g., swelling, rash), official guidance advises discontinuing the use of the spray.

In such cases, official safety guidance further advises seeking advice from a healthcare professional.


Q: Is it normal to feel a mild burning or stinging sensation when using the spray?

A: Official product information typically lists reactions classified as rare, such as hypersensitivity reactions.

Sensations like mild burning or stinging may occur in some individuals. If this feeling is persistent, severe, or causes significant discomfort, official safety information suggests consulting a healthcare professional.


Q: Can Nasic-cur be used if the nasal lining is already cracked or has small wounds?

A: Official indications for Dexpanthenol nasal spray include supportive treatment for the healing of damaged or irritated nasal mucosa.

This supportive use is generally applied in situations such as dryness, irritation, small lesions, or superficial wounds on the nasal lining.


Q: Is there evidence that Nasic-cur is effective for dry nose caused by air conditioning or heating?

A: Yes, clinical evidence for Dexpanthenol supports its application in managing nasal dryness and irritation, including that which is related to environmental factors.

Dryness caused by dry air, air conditioning, or heating is one of the common scenarios where Dexpanthenol monotherapy is used to support mucosal recovery.


Q: Does Nasic-cur work for a runny nose, or is it only for dryness?

A: The primary indication is for the supportive healing of damaged or dry nasal mucosa.

Because Nasic-cur does not contain active ingredients like decongestants or antihistamines, it is not specifically indicated for the symptomatic relief of a runny nose (rhinorrhea).


Q: How long after opening should I stop using a bottle of Nasic-cur?

A: The product labeling specifies an in-use stability period to maintain quality and hygiene.

Once opened, the nasal spray must be discarded after 3 months (or as specified on your local product label), even if the bottle still contains some solution.


Q: Can this product be used by elderly people with chronic dry nose issues?

A: Regulatory documents do not list advanced age as a contraindication, nor do they specify a required dose adjustment for the elderly population.

It is generally considered eligible for use in adults, provided there are no contraindications such as a known hypersensitivity to the ingredients.


Q: Is Nasic-cur effective for damage caused by repeated use of decongestants?

A: Dexpanthenol is indicated for the supportive healing of damaged nasal mucosa.

Studies and official information confirm its use in supporting epithelial recovery in cases of mucosal damage, including damage that may result from the overuse of other nasal sprays (a condition known as rhinitis medicamentosa).


Q: What research has been done on dexpanthenol for nasal healing?

A: Research has primarily focused on Dexpanthenol's role as a provitamin that converts to Vitamin B5 inside the cells.

This conversion supports epithelial cell proliferation and helps maintain the integrity of the mucosal barrier. Studies have examined its application for nasal dryness, irritation, and post-surgical care.


Q: What happens if I forget to use a dose of Nasic-cur?

A: Official product information for Dexpanthenol does not provide a specific instruction for missed doses.

It is generally advised to simply resume the regular schedule when the next dose is due and not use a double dose to make up for the forgotten application.


Q: Why must the bottle be held upright when administering the spray?

A: The manufacturer's instructions require holding the bottle upright for the metered-dose pump to function as intended.

This ensures the pump draws the correct amount of solution and dispenses a fine, reliably measured mist, which is necessary for the optimal distribution of the medicine on the nasal lining.


Q: Can I use Nasic-cur if I have a history of heart issues or high blood pressure?

A: The official regulatory profile for Dexpanthenol nasal spray does not list systemic cardiovascular conditions, such as heart issues or high blood pressure, as a specific contraindication or precaution for use.

This is because the medicine is applied locally to the nasal lining and has a low potential for systemic effects.


Q: Can I use Nasic-cur if I have a cold, or only after the cold is over?

A: The product’s primary purpose is to support the healing of dry or damaged nasal mucosa, a condition often associated with a cold.

This supportive use is appropriate during a cold to help manage associated irritation or dryness, even though the product does not treat the viral cold itself.


Q: Is there a version of Nasic-cur that is preservative-free?

A: Specific local regulations or formulations determine the use of preservatives in medicinal products.

While preservative-free Dexpanthenol nasal spray formulations exist in clinical literature, confirmation of the specific product's composition generally requires referring to the excipient list on the local product label or consulting a pharmacist.

How should Nasic-cur be stored and disposed of?

How to Store and Dispose of Nasic-cur?

The storage and disposal of this medicine must adhere strictly to the conditions specified in official regulatory labeling.


Storage Conditions

Official documents mandate that the nasal spray not be stored above 25°C and must be kept in its original container.

Constraint Requirement
Maximum Temperature Store below 25°C.
In-Use Stability Discard after 3 months from the first opening.
Child Safety Keep out of the sight and reach of children.

Disposal Requirements

Unused or expired Nasic-cur must not be thrown away via wastewater or household waste. Regulatory rules require that medicines be disposed of according to instructions provided by the pharmacist or via local regulations to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nasic-cur found in:

A-Z Index: